About GPhA

Siobhan Barr
Celerion

Paul Bisaro*
Watson Pharmaceuticals, Inc.

Doug Boothe
Actavis Inc.

Chuck Caprariello
Ranbaxy Pharmaceuticals

Andras Csontos
Geodeon Richter USA

Miles Davis
Sovereign Laboratories

Rosendo Ferran*
New Chemic, Inc.

Jeff Glazer
Heritage Pharmaceuticals

David Hanson
Interchem Corporation

David Klaum*
Fougera (Nycomed U.S., Inc.)

Patrick LePore
Par Pharmaceuticals

Ed Maloney
Paddock Laboratories

William Marth*
Teva North America

Tony Mauro*
Mylan Pharmaceuticals

Tom Murphy
Ben Venue Laboratories, Inc.

Joseph Renner*
Zydus Pharmaceuticals USA Inc.

Bill Seiden
Taro Pharmaceuticals USA

Tom Silberg
APP Pharmaceuticals LLC

KL Spear
Spear Pharmaceuticals

Ambrose Stafford
Apicore LLC

Vincent Ursino
Vinchem, Inc.

Craig Wheeler*
Momenta Pharmaceuticals

George Zorich
Bioniche Pharma Group

Chairman
Paul Bisaro
President and CEO
Watson Pharmaceuticals, Inc.

Secretary/Treasurer
Rosendo Ferran
Senior Consultant
New Chemic, Inc.

Joseph Renner
President and CEO
Zydus Pharmaceuticals USA Inc.

Craig Wheeler
President and CEO
Momenta Pharmaceuticals

Vice Chair
Anthony Mauro
President
Mylan Pharmaceuticals

William Marth
President and CEO
Teva North America

David Klaum
Senior Vice President and General Manager
Fougera (Nycomed U.S., Inc.)